Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Julia Hippisley‐Cox, Duncan Young, Carol Coupland, et al.
Heart (2020) Vol. 106, Iss. 19, pp. 1503-1511
Open Access | Times Cited: 350

Showing 1-25 of 350 citing articles:

Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension
Bin Zhou, Pablo Perel, George A. Mensah, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 11, pp. 785-802
Open Access | Times Cited: 984
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
David Halpin, Gerard J. Criner, Alberto Papi, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 203, Iss. 1, pp. 24-36
Open Access | Times Cited: 642
Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study
Min Gao, Carmen Piernas, Nerys M. Astbury, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 6, pp. 350-359
Open Access | Times Cited: 472
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Norbert Stefan, Andreas L. Birkenfeld, Matthias B. Schulze
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 3, pp. 135-149
Open Access | Times Cited: 416
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)
David Simons, Lion Shahab, Jamie Brown, et al.
Addiction (2020) Vol. 116, Iss. 6, pp. 1319-1368
Open Access | Times Cited: 361
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
Julia Hippisley‐Cox, Martina Patone, Xue W. Mei, et al.
BMJ (2021), pp. n1931-n1931
Open Access | Times Cited: 320
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study
Julia Hippisley‐Cox, Carol Coupland, Nisha Mehta, et al.
BMJ (2021), pp. n2244-n2244
Open Access | Times Cited: 283
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
Matthias P. Nägele, Bernhard J. Haubner, Felix C. Tanner, et al.
Atherosclerosis (2020) Vol. 314, pp. 58-62
Open Access | Times Cited: 274
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort
Ashley Kieran Clift, Adam Von Ende, Pui San Tan, et al.
Thorax (2021) Vol. 77, Iss. 1, pp. 65-73
Open Access | Times Cited: 166
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19
Ranu Baral, Vasiliki Tsampasian, Maciej Dębski, et al.
JAMA Network Open (2021) Vol. 4, Iss. 3, pp. e213594-e213594
Open Access | Times Cited: 114
Antihypertensive Drugs and COVID-19 Risk
Laura Semenzato, Jérémie Botton, Jérôme Drouin, et al.
Hypertension (2021) Vol. 77, Iss. 3, pp. 833-842
Open Access | Times Cited: 111
Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada
Michael A. Campitelli, Susan E. Bronskill, Laura C. Maclagan, et al.
JAMA Network Open (2021) Vol. 4, Iss. 8, pp. e2118441-e2118441
Open Access | Times Cited: 110
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study
Martina Patone, Karen Thomas, Robert Alan Hatch, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 11, pp. 1518-1528
Open Access | Times Cited: 97
Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England
Defne Saatci, Tom A. Ranger, César Garriga, et al.
JAMA Pediatrics (2021) Vol. 175, Iss. 9, pp. 928-928
Open Access | Times Cited: 91
Impact of Sex and Metabolic Comorbidities on Coronavirus Disease 2019 (COVID-19) Mortality Risk Across Age Groups: 66 646 Inpatients Across 613 U.S. Hospitals
Katherine E. Goodman, Laurence S. Magder, Jonathan Baghdadi, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 11, pp. e4113-e4123
Open Access | Times Cited: 83
Coronavirus disease 2019 and cardiovascular complications: focused clinical review
Sahrai Saeed, Marijana Tadić, Terje H. Larsen, et al.
Journal of Hypertension (2021) Vol. 39, Iss. 7, pp. 1282-1292
Open Access | Times Cited: 82
Hypertension, a Moving Target in COVID-19
Carmine Savoia, Massimo Volpe, Reinhold Kreutz
Circulation Research (2021) Vol. 128, Iss. 7, pp. 1062-1079
Open Access | Times Cited: 81
Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic
Sakir Ahmed, Armen Yuri Gasparyan, Olena Zimba
Rheumatology International (2021) Vol. 41, Iss. 2, pp. 243-256
Open Access | Times Cited: 69
COVID-19-Associated Cardiovascular Complications
Clement C. E. Lee, Kashan Ali, David Connell, et al.
Diseases (2021) Vol. 9, Iss. 3, pp. 47-47
Open Access | Times Cited: 69
Potential detrimental role of soluble ACE2 in severe COVID‐19 comorbid patients
Mahmudur Rahman, Maruf Hasan, Asif Ahmed
Reviews in Medical Virology (2021) Vol. 31, Iss. 5, pp. 1-12
Open Access | Times Cited: 68
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 62
SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association
Pei‐Ni Jone, Anitha S. John, Matthew E. Oster, et al.
Circulation (2022) Vol. 145, Iss. 19
Open Access | Times Cited: 61
Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes
Ceren Güney, Fatma Akar
Journal of Pharmacy & Pharmaceutical Sciences (2021) Vol. 24, pp. 84-93
Open Access | Times Cited: 59
Risk factors for hospitalization among persons with COVID-19—Colorado
Grace M. Vahey, Emily G. McDonald, Kristen E. Marshall, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0256917-e0256917
Open Access | Times Cited: 57
Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target
Pasquale Ambrosino, Ilenia Calcaterra, Marco Mosella, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 812-812
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top